Rare diseases reconsidered.
作者信息
Lougheed Tim
出版信息
CMAJ. 2013 May 14;185(8):E315-6. doi: 10.1503/cmaj.109-4456. Epub 2013 Apr 2.
Abstract
摘要
相似文献
1
Rare diseases reconsidered.
CMAJ. 2013 May 14;185(8):E315-6. doi: 10.1503/cmaj.109-4456. Epub 2013 Apr 2.
2
New cystic fibrosis drug paves the way for orphan diseases.
Lancet Respir Med. 2013 Apr;1(2):104. doi: 10.1016/S2213-2600(13)70027-4. Epub 2013 Mar 6.
3
Patients with rare diseases: from therapeutic orphans to pioneers of personalized treatments.
EMBO Mol Med. 2018 Jan;10(1):1-3. doi: 10.15252/emmm.201708365.
4
[Inaugural conference: Progress made in the Second National Plan for Rare Diseases].
Presse Med. 2012 May;41 Suppl 1:S3-5. doi: 10.1016/j.lpm.2012.02.021. Epub 2012 Apr 6.
5
Rare diseases: Genomics, plain and simple.
Nature. 2012 Feb 29;483(7387):20-2. doi: 10.1038/483020a.
6
Gene therapy: Industrial strength.
Nature. 2016 Sep 8;537(7619):S57-9. doi: 10.1038/537S57a.
7
[Round table 4. Speeding new therapeutic approaches for rare diseases: do we need new economical models or financial tools?].
Med Sci (Paris). 2014 Apr;30 Spe(1):47-53. doi: 10.1051/medsci/201430s111. Epub 2014 Apr 14.
8
[The conference, "rare diseases not only in the curriculum" in Szczecin].
Wiad Lek. 2014;67(4):569-70.
9
Editorial comment.
Curr Opin Urol. 2017 Jan;27(1):34. doi: 10.1097/MOU.0000000000000358.
10
Taking Control of Castleman Disease: Leveraging Precision Medicine Technologies to Accelerate Rare Disease Research.
Yale J Biol Med. 2015 Nov 24;88(4):383-8. eCollection 2015 Dec.
Zotero 插件